Volume 11, Number 2—February 2005
Research
Human Disease from Influenza A (H5N1), Thailand, 2004
Tawee Chotpitayasunondh*, Kumnuan Ungchusak†, Wanna Hanshaoworakul†, Supamit Chunsuthiwat†, Pathom Sawanpanyalert†, Rungruen Kijphati†, Sorasak Lochindarat*, Panida Srisan*, Pongsan Suwan†, Yutthasak Osotthanakorn†, Tanakorn Anantasetagoon†, Supornchai Kanjanawasri†, Sureeporn Tanupattarachai†, Jiranun Weerakul†, Ruangsri Chaiwirattana†, Monthira Maneerattanaporn†, Rapol Poolsavatkitikool†, Kulkunya Chokephaibulkit‡, Anucha Apisarnthanarak§, and Scott F. Dowell¶
Figure 4
Figure 4. Timing of the clinical course and oseltamivir treatment for 4 patients who survived and 8 patients who died of human influenza A (H5N1) infection, Thailand, 2004.
Page created: April 28, 2011
Page updated: April 28, 2011
Page reviewed: April 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.